High-Potent Oral Solid Dosage Contract Manufacturing Market Grows at 8.8% CAGR, Projected to Reach $15.32B by 2035

The high-potent oral solid dosage contract manufacturing market is gaining remarkable traction due to rising demand for safe and effective high-potency medications. As more pharmaceutical companies focus on outsourcing their manufacturing needs to reduce costs and enhance efficiency, this market is seeing a substantial rise. With an increasing number of drugs categorized as high-potency, especially …